Go Pro

Bowhead Specialty (NYSE:BOW) Given New $33.00 Price Target at JPMorgan Chase & Co.

Bowhead Specialty logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • JPMorgan Chase & Co. raised Bowhead Specialty’s price target from $30 to $33 while keeping a neutral rating, implying about 7.06% upside from the prior close.
  • Other analysts have also been adjusting targets higher, and the stock now has a Moderate Buy consensus with an average price target of $33.71.
  • Bowhead Specialty shares were up 0.4% to $30.82, and the company recently reported EPS of $0.48, beating estimates, though revenue came in below expectations.
  • Five stocks we like better than Bowhead Specialty.

Bowhead Specialty (NYSE:BOW - Get Free Report) had its price objective lifted by investment analysts at JPMorgan Chase & Co. from $30.00 to $33.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price objective indicates a potential upside of 7.06% from the company's previous close.

BOW has been the subject of a number of other research reports. Keefe, Bruyette & Woods lifted their target price on Bowhead Specialty from $34.00 to $36.00 and gave the stock an "outperform" rating in a report on Wednesday, July 8th. UBS Group set a $28.00 price target on Bowhead Specialty in a report on Thursday, May 21st. Morgan Stanley lifted their price objective on Bowhead Specialty from $28.00 to $30.00 and gave the stock an "equal weight" rating in a report on Monday, July 6th. Royal Bank Of Canada upped their target price on shares of Bowhead Specialty from $30.00 to $38.00 and gave the company an "outperform" rating in a research note on Monday, July 13th. Finally, Piper Sandler raised their price target on shares of Bowhead Specialty from $32.00 to $36.00 and gave the company an "overweight" rating in a report on Wednesday, July 15th. Five equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $33.71.

Read Our Latest Analysis on BOW

Bowhead Specialty Stock Up 0.4%

NYSE:BOW traded up $0.12 on Monday, reaching $30.82. 11,913 shares of the stock traded hands, compared to its average volume of 206,857. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $1.01 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 0.92 and a beta of -0.10. Bowhead Specialty has a 12 month low of $21.21 and a 12 month high of $33.88. The company's fifty day simple moving average is $28.49 and its 200 day simple moving average is $25.80.

Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.06. The firm had revenue of $155.69 million for the quarter, compared to the consensus estimate of $211.74 million. Bowhead Specialty had a net margin of 9.99% and a return on equity of 13.80%. Equities analysts predict that Bowhead Specialty will post 1.97 EPS for the current fiscal year.

Institutional Investors Weigh In On Bowhead Specialty

A number of large investors have recently made changes to their positions in the company. Bleakley Financial Group LLC purchased a new stake in Bowhead Specialty during the fourth quarter valued at approximately $1,086,000. FJ Capital Management LLC bought a new stake in shares of Bowhead Specialty during the 4th quarter valued at $1,122,000. Knights of Columbus Asset Advisors LLC increased its stake in shares of Bowhead Specialty by 40.2% in the 4th quarter. Knights of Columbus Asset Advisors LLC now owns 69,813 shares of the company's stock worth $1,992,000 after purchasing an additional 20,032 shares in the last quarter. Dockside LLC bought a new position in Bowhead Specialty in the 4th quarter worth $1,070,000. Finally, Langdon Equity Partners purchased a new position in Bowhead Specialty during the fourth quarter valued at $28,000.

Bowhead Specialty Company Profile

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Further Reading

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines